242 related articles for article (PubMed ID: 36992153)
1. Chikungunya Virus: Priority Pathogen or Passing Trend?
Montalvo Zurbia-Flores G; Reyes-Sandoval A; Kim YC
Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992153
[TBL] [Abstract][Full Text] [Related]
2. A Review on Chikungunya Virus Epidemiology, Pathogenesis and Current Vaccine Development.
de Lima Cavalcanti TYV; Pereira MR; de Paula SO; Franca RFO
Viruses; 2022 May; 14(5):. PubMed ID: 35632709
[TBL] [Abstract][Full Text] [Related]
3. The research progress of Chikungunya fever.
Cai L; Hu X; Liu S; Wang L; Lu H; Tu H; Huang X; Tong Y
Front Public Health; 2022; 10():1095549. PubMed ID: 36699921
[TBL] [Abstract][Full Text] [Related]
4. Preparation of vesicular stomatitis virus pseudotype with Chikungunya virus envelope protein.
Tong W; Yin XX; Lee BJ; Li YG
Acta Virol; 2015 Jun; 59(2):189-93. PubMed ID: 26104337
[TBL] [Abstract][Full Text] [Related]
5. 51 years in of Chikungunya clinical vaccine development: A historical perspective.
Reyes-Sandoval A
Hum Vaccin Immunother; 2019; 15(10):2351-2358. PubMed ID: 30735447
[TBL] [Abstract][Full Text] [Related]
6. Recent Progress in Vaccine Development Against Chikungunya Virus.
Gao S; Song S; Zhang L
Front Microbiol; 2019; 10():2881. PubMed ID: 31921059
[TBL] [Abstract][Full Text] [Related]
7. Genetic Characterization of Chikungunya Virus in Field-Caught
Intayot P; Phumee A; Boonserm R; Sor-Suwan S; Buathong R; Wacharapluesadee S; Brownell N; Poovorawan Y; Siriyasatien P
Pathogens; 2019 Aug; 8(3):. PubMed ID: 31382507
[TBL] [Abstract][Full Text] [Related]
8. Chikungunya Virus: An Emergent Arbovirus to the South American Continent and a Continuous Threat to the World.
Cunha MS; Costa PAG; Correa IA; de Souza MRM; Calil PT; da Silva GPD; Costa SM; Fonseca VWP; da Costa LJ
Front Microbiol; 2020; 11():1297. PubMed ID: 32670231
[TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology, evolution and phylogeny of Chikungunya virus: An updating review.
Lo Presti A; Cella E; Angeletti S; Ciccozzi M
Infect Genet Evol; 2016 Jul; 41():270-278. PubMed ID: 27085290
[TBL] [Abstract][Full Text] [Related]
10. Chikungunya Virus-Induced Arthritis: Role of Host and Viral Factors in the Pathogenesis.
Amdekar S; Parashar D; Alagarasu K
Viral Immunol; 2017 Dec; 30(10):691-702. PubMed ID: 28910194
[TBL] [Abstract][Full Text] [Related]
11. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.
Taylor A; Liu X; Zaid A; Goh LY; Hobson-Peters J; Hall RA; Merits A; Mahalingam S
mBio; 2017 Feb; 8(1):. PubMed ID: 28223458
[TBL] [Abstract][Full Text] [Related]
12. Interferon-induced restriction of Chikungunya virus infection.
Suzuki Y
Antiviral Res; 2023 Feb; 210():105487. PubMed ID: 36657882
[TBL] [Abstract][Full Text] [Related]
13. The global emergence of Chikungunya infection: An integrated view.
Manzoor KN; Javed F; Ejaz M; Ali M; Mujaddadi N; Khan AA; Khattak AA; Zaib A; Ahmad I; Saeed WK; Manzoor S
Rev Med Virol; 2022 May; 32(3):e2287. PubMed ID: 34428335
[TBL] [Abstract][Full Text] [Related]
14. Chikungunya Virus Vaccine Candidates with Decreased Mutational Robustness Are Attenuated
Carrau L; Rezelj VV; Noval MG; Levi LI; Megrian D; Blanc H; Weger-Lucarelli J; Moratorio G; Stapleford KA; Vignuzzi M
J Virol; 2019 Sep; 93(18):. PubMed ID: 31270226
[TBL] [Abstract][Full Text] [Related]
15. Molecular Virologic and Clinical Characteristics of a Chikungunya Fever Outbreak in La Romana, Dominican Republic, 2014.
Langsjoen RM; Rubinstein RJ; Kautz TF; Auguste AJ; Erasmus JH; Kiaty-Figueroa L; Gerhardt R; Lin D; Hari KL; Jain R; Ruiz N; Muruato AE; Silfa J; Bido F; Dacso M; Weaver SC
PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005189. PubMed ID: 28030537
[TBL] [Abstract][Full Text] [Related]
16. A Rodent Model of Chikungunya Virus Infection in RAG1 -/- Mice, with Features of Persistence, for Vaccine Safety Evaluation.
Seymour RL; Adams AP; Leal G; Alcorn MD; Weaver SC
PLoS Negl Trop Dis; 2015; 9(6):e0003800. PubMed ID: 26115459
[TBL] [Abstract][Full Text] [Related]
17. Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by
Delang L; Yen PS; Vallet T; Vazeille M; Vignuzzi M; Failloux AB
mSphere; 2018 Aug; 3(4):. PubMed ID: 30135220
[TBL] [Abstract][Full Text] [Related]
18. Chikungunya virus infection: molecular biology, clinical characteristics, and epidemiology in Asian countries.
Khongwichit S; Chansaenroj J; Chirathaworn C; Poovorawan Y
J Biomed Sci; 2021 Dec; 28(1):84. PubMed ID: 34857000
[TBL] [Abstract][Full Text] [Related]
19. Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice.
Fumagalli MJ; de Souza WM; de Castro-Jorge LA; de Carvalho RVH; Castro ÍA; de Almeida LGN; Consonni SR; Zamboni DS; Figueiredo LTM
J Virol; 2021 Nov; 95(23):e0112221. PubMed ID: 34549980
[TBL] [Abstract][Full Text] [Related]
20. Proteomic profiling of chikungunya virus-infected human muscle cells: reveal the role of cytoskeleton network in CHIKV replication.
Issac TH; Tan EL; Chu JJ
J Proteomics; 2014 Aug; 108():445-64. PubMed ID: 24933005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
